BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 3865572)

  • 1. Adenosine deaminase in disorders of purine metabolism and in immune deficiency.
    Ann N Y Acad Sci; 1985; 451():1-345. PubMed ID: 3865572
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adenosine deaminase activity and immunologic deficiency].
    Bank H; Brook-Simoni P; Ramot B
    Harefuah; 1977 Nov; 93(9):257-8. PubMed ID: 598766
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.
    Seegmiller JE
    Monogr Hum Genet; 1978; 10():88-91. PubMed ID: 102926
    [No Abstract]   [Full Text] [Related]  

  • 7. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
    Goday A; Simmonds HA; Webster DR; Morris GS
    Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive correlation between adenosine deaminase activity and superoxide formation during phagocytosis.
    Tritsch GL; Niswander PW
    J Med; 1980; 11(5-6):393-9. PubMed ID: 6300272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase deficiency and severe combined immunodeficiency disease.
    Thompson LF; Seegmiller JE
    Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772
    [No Abstract]   [Full Text] [Related]  

  • 12. Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Sahota A; Potter CF; Cameron JS
    Clin Sci Mol Med; 1978 May; 54(5):579-84. PubMed ID: 108044
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview of possible relation of defects in purine metabolism to immune deficiency.
    Seegmiller JE
    Ann N Y Acad Sci; 1985; 451():9-19. PubMed ID: 3935028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adenosine deaminase and nucleoside phosphorylase: a new approach to the etiopathogenesis of various immunologic deficiencies].
    Lucivero G; Dammacco F; Bonomo L
    Recenti Prog Med; 1977 Sep; 63(3):275-88. PubMed ID: 413174
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenosine deaminase and nucleoside phosphorylase activity in patients with immunodeficiency syndromes.
    Chen SH; Ochs HD; Scott CR; Giblett ER
    Clin Immunol Immunopathol; 1979 Jun; 13(2):156-60. PubMed ID: 110506
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 17. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adenosine deaminase deficiency and severe combined immunodeficiency].
    Ueland PM
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):274-6. PubMed ID: 7385150
    [No Abstract]   [Full Text] [Related]  

  • 19. Human adenosine deaminase and its binding protein in normal and adenosine deaminase-deficient fibroblast cell strains.
    Daddona PE; Frohman MA; Kelley WN
    J Biol Chem; 1980 Jun; 255(12):5681-7. PubMed ID: 7380831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adenosine deaminase activity and immune dysfunction (author's transl)].
    Bremer H; Bauer I; Brock J
    Allerg Immunol (Leipz); 1981; 27(1):3-13. PubMed ID: 6455054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.